In our cohort, elevated α2-globulin levels were observed in prostate cancer patients; however, after adjustment for inflammatory markers (neutrophil-to-lymphocyte ratio and fibrinogen), age, PSA, and biopsy results, α2-globulin was not independently associated with MGUS. This evidence concerns the gene KLK3 and prostate carcinoma.